A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT01106599 · COMPLETED
Trial details
- NCT number
- NCT01106599
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2014-08-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.